(Q81509434)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18574441%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

title

Tandem high-dose chemotherapy and autologous stem cell rescue in children with bilateral advanced retinoblastoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18574441%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

S H Lee

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18574441%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

K H Yoo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18574441%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

K W Sung

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18574441%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

J Y Kim

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18574441%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

E J Cho

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18574441%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

H H Koo

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18574441%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

S E Chung

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18574441%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

S W Kang

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18574441%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

S Y Oh

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18574441%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

D-I Ham

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18574441%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Y-D Kim

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18574441%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

publication date

23 June 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18574441%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

9 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18574441%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18574441%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18574441%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

385-391

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18574441%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/bmt.2008.181

9 January 2020

exact match

0 references

cites work

Incidence of second neoplasms in patients with bilateral retinoblastoma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.181

7 January 2021

Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.181

7 January 2021

Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.181

7 January 2021

Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.181

7 January 2021

First-line chemotherapy with local treatment can prevent external-beam irradiation and enucleation in low-stage intraocular retinoblastoma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.181

7 January 2021

Globe conserving treatment of the only eye in bilateral retinoblastoma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.181

7 January 2021

High-risk neuroblastoma treated with tandem autologous peripheral-blood stem cell-supported transplantation: long-term survival update

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.181

7 January 2021

High-dose chemotherapy and autologous stem cell rescue in children with newly diagnosed high-risk or relapsed medulloblastoma or supratentorial primitive neuroectodermal tumor

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.181

7 January 2021

Tandem high-dose chemotherapy and autologous stem cell rescue in patients over 1 year of age with stage 4 neuroblastoma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.181

7 January 2021

Treatment of High-Risk Neuroblastoma With Triple-Tandem High-Dose Therapy and Stem-Cell Rescue: Results of the Chicago Pilot II Study

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.181

7 January 2021

High-dose chemotherapy with carboplatin, etoposide and cyclophosphamide followed by a haematopoietic stem cell rescue in patients with high-risk retinoblastoma: a SFOP and SFGM study

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.181

7 January 2021

Successful treatment of metastatic retinoblastoma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.181

7 January 2021

High-dose chemotherapy with autologous stem cell rescue in children with retinoblastoma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.181

7 January 2021

A multidisciplinary treatment strategy that includes high-dose chemotherapy for metastatic retinoblastoma without CNS involvement

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.181

7 January 2021

Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.181

7 January 2021

Outcome following initial external beam radiotherapy in patients with Reese-Ellsworth group Vb retinoblastoma.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.181

7 January 2021

Clinicopathologic features of retinoblastoma after primary chemoreduction.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.181

7 January 2021

Histopathologic findings in eyes with retinoblastoma treated only with chemoreduction

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.181

7 January 2021

High-dose chemotherapy and autologous stem cell transplantation for primary refractory or relapsed Hodgkin lymphoma: long-term outcome in the first 100 patients treated in Vancouver

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.181

7 January 2021

Outcome and prognostic factors in advanced Hodgkin's disease treated with high-dose chemotherapy and autologous stem cell transplantation: a study of 341 patients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.181

7 January 2021

Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin's disease: a report from the German Hodgkin's Lymphoma Study Group

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.181

7 January 2021

Secondary leukemia following high cumulative doses of etoposide in patients treated for advanced germ cell tumors

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.181

7 January 2021

Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Ca

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.181

7 January 2021